Samantha Brandler

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. ncbi A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
    Samantha Brandler
    Unité de Génomique Virale et Vaccination, Institut Pasteur, CNRS URA 3015, 28 rue du Dr Roux, 75724 Paris Cedex 15, France
    Vaccine 31:3718-25. 2013
  2. pmc Vaccines in development against West Nile virus
    Samantha Brandler
    Unité de Génomique Virale et Vaccination, Institut Pasteur, 28 rue du Dr Roux, Paris 75015, France
    Viruses 5:2384-409. 2013
  3. doi Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
    Samantha Brandler
    Viral Genomics and Vaccination Unit, Institut Pasteur, CNRS URA3015, 28 rue du Dr Roux, 75015 Paris, France
    Vaccine 28:6730-9. 2010
  4. pmc Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus
    Samantha Brandler
    Viral Genomics and Vaccination Laboratory, Institut Pasteur, CNRS URA3015, Paris, France
    PLoS Negl Trop Dis 1:e96. 2007
  5. doi Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic
    Mathilde Guerbois
    Laboratoire de Génomique Virale et Vaccination, CNRS URA 3015, Institut Pasteur, Paris Cedex 15, France
    Virology 388:191-203. 2009
  6. doi Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection
    Samantha Brandler
    Viral Genomics and Vaccination Unit, Institut Pasteur, Paris, France
    J Infect Dis 206:212-9. 2012
  7. pmc Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect
    Samantha Brandler
    Unité Virus et Immunite, Institut Pasteur, URA CNRS 3015, Paris, France
    J Virol 84:5314-28. 2010
  8. pmc The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
    Nicoletta Casartelli
    Unité Virus et Immunite, Institut Pasteur, 75724 Paris Cedex 15, France
    J Exp Med 207:39-49. 2010
  9. ncbi Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines
    Samantha Brandler
    Viral Genomics and Vaccination Laboratory, CNRS URA3015, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France
    Comp Immunol Microbiol Infect Dis 31:271-91. 2008

Collaborators

Detail Information

Publications9

  1. ncbi A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
    Samantha Brandler
    Unité de Génomique Virale et Vaccination, Institut Pasteur, CNRS URA 3015, 28 rue du Dr Roux, 75724 Paris Cedex 15, France
    Vaccine 31:3718-25. 2013
    ..Measles vaccine is one of the safest and most effective human vaccines. A recombinant MV-CHIKV virus could make a safe and effective vaccine against chikungunya that deserves to be further tested in human trials. ..
  2. pmc Vaccines in development against West Nile virus
    Samantha Brandler
    Unité de Génomique Virale et Vaccination, Institut Pasteur, 28 rue du Dr Roux, Paris 75015, France
    Viruses 5:2384-409. 2013
    ....
  3. doi Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
    Samantha Brandler
    Viral Genomics and Vaccination Unit, Institut Pasteur, CNRS URA3015, 28 rue du Dr Roux, 75015 Paris, France
    Vaccine 28:6730-9. 2010
    ..A combined measles-dengue vaccine might be attractive to immunize infants against both diseases where they co-exist...
  4. pmc Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus
    Samantha Brandler
    Viral Genomics and Vaccination Laboratory, Institut Pasteur, CNRS URA3015, Paris, France
    PLoS Negl Trop Dis 1:e96. 2007
    ..The protective efficacy of this vaccine should be studied in non-human primates. A combined measles-dengue vaccine might provide a one-shot approach to immunize children against both diseases where they co-exist...
  5. doi Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic
    Mathilde Guerbois
    Laboratoire de Génomique Virale et Vaccination, CNRS URA 3015, Institut Pasteur, Paris Cedex 15, France
    Virology 388:191-203. 2009
    ..This candidate vaccine will be next tested in non-human primates. As a pediatric vaccine, it might protect children and adolescents simultaneously from measles and HIV...
  6. doi Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection
    Samantha Brandler
    Viral Genomics and Vaccination Unit, Institut Pasteur, Paris, France
    J Infect Dis 206:212-9. 2012
    ..This study demonstrates for the first time the capacity of a recombinant live attenuated measles vector to protect nonhuman primates from a heterologous infectious challenge...
  7. pmc Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect
    Samantha Brandler
    Unité Virus et Immunite, Institut Pasteur, URA CNRS 3015, Paris, France
    J Virol 84:5314-28. 2010
    ..Deciphering the immune responses to MVA in culture experiments will help in the design of innovative vaccine strategies...
  8. pmc The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells
    Nicoletta Casartelli
    Unité Virus et Immunite, Institut Pasteur, 75724 Paris Cedex 15, France
    J Exp Med 207:39-49. 2010
    ..Our results reveal a novel function for A3G, acting not only as an intrinsic antiviral factor but also as an inducer of the adaptive immune system...
  9. ncbi Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines
    Samantha Brandler
    Viral Genomics and Vaccination Laboratory, CNRS URA3015, Institut Pasteur, 28 rue du Dr Roux, 75015 Paris, France
    Comp Immunol Microbiol Infect Dis 31:271-91. 2008
    ..Recombinant live attenuated MV might be used as bivalent vaccination vector to mass immunize children and adolescents against both measles and flaviviral diseases such as Dengue or Japanese Encephalitis in the developing world...